Indefinite Delivery Contract SPE2DX25D2000

Award Date 3/7/25
Last Date to Order 3/6/35
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award was issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award Indefinite Delivery Contract (IDC), valued at $999,999,999, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities...
The federal contract IDV award, valued at $999,999,999.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award indefinite delivery contract (IDC) spans from August 2025 through December 2036, providing worldwide pharmaceutical and medical supply support to various Department of Defense (DoD) customers, including the Defense Health Agency, US Coast...
The federal contract IDV award SPE2DR25D1205 is a $999,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a 30-month base period with three 30-month option periods, running through December 2036. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $999,999,999, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC serves as a prime...
The federal contract IDV award, valued at $9,999,999,999, was granted to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The single-award Indefinite Delivery Contract (IDC) has an ultimate completion date of December 31, 2036 and covers the procurement of a comprehensive range of pharmaceutical and medical products to support various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, and U.S. Naval...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, aims to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency,...
The federal contract IDV award SPE2DR25D6038 is a single-award, unrestricted Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by Amerisourcebergen Drug Corp. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), the U.S. Coast Guard, and the U.S. Naval Fleet. The contract covers a broad range of...
The federal contract IDV award is a single award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract has an ultimate completion date of December 31, 2036 and provides worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, United States Coast...
The Indefinite Delivery Contract SPE2DR25D2103 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, aims to establish a Pharmaceutical Prime Vendor Global Program Generation V to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), U.S. Coast...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, runs through December 2026 and aims to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, the U.S. Coast Guard, and U.S. Naval Fleet. The contract...

The federal contract IDV award SPE2DX25D2000 was issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award indefinite delivery contract, valued at $999,999,999, is intended to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, US Coast Guard, and US Naval Fleet.

The contract encompasses a comprehensive range of medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains, including cardiovascular health, diabetes management, mental health treatments, pain management, infectious disease prevention, and general medical care. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion for the overall procurement. The contract is an unrestricted, fully competitive acquisition, with awards made on a regional basis to at least three different contractors to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters.

Generated 6/6/25, 9:52 AM